ES2099159T3 - Uso de derivados de lipasa estimulada por sales biliares humanas para la preparacion de medicamentos. - Google Patents
Uso de derivados de lipasa estimulada por sales biliares humanas para la preparacion de medicamentos.Info
- Publication number
- ES2099159T3 ES2099159T3 ES91911030T ES91911030T ES2099159T3 ES 2099159 T3 ES2099159 T3 ES 2099159T3 ES 91911030 T ES91911030 T ES 91911030T ES 91911030 T ES91911030 T ES 91911030T ES 2099159 T3 ES2099159 T3 ES 2099159T3
- Authority
- ES
- Spain
- Prior art keywords
- preparation
- lipase
- medicines
- new
- dna sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/596—Mixtures of surface active compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
LA INVENCION SE REFIERE A NUEVAS SECUENCIAS DE DNA, A NUEVAS PROTEINAS CODIFICADAS PARA DICHAS SECUENCIAS DE DNA, Y AL USO DE TALES PROTEINAS. LA INVENCION TAMBIEN PRESENTA VECTORES, TAL COMO CONSTRUCCIONES PLASMIDAS, QUE COMPRENDEN TALES SECUENCIAS DE DNA, QUE SON CAPACES DE EXPRESAR LA ENZIMA DESEADA. LA INVENCION TAMBIEN INCLUYE ORGANISMOS ANFITRIONES TRANSFECTADOS CON TALES CONSTRUCCIONES, POR EJEMPLO LEVADURA DE BACTERIAS, CELULAS DE MAMIFEROS, Y ANIMALES TRANSGENICAS. LA INVENCION TAMBIEN INCLUYE UN PROCESO PARA LA PREPARACION DE LOS NUEVOS PRODUCTOS DE LA INVENCION. LAS NUEVAS PROTEINAS ESTAN RELACIONADAS CON UNA ENZIMA, CONOCIDA COMO LIPASA ESTIMULADA POR LA SAL DE BILIS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9001985A SE9001985D0 (sv) | 1990-06-01 | 1990-06-01 | New chemical products |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2099159T3 true ES2099159T3 (es) | 1997-05-16 |
Family
ID=20379662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES91911030T Expired - Lifetime ES2099159T3 (es) | 1990-06-01 | 1991-05-30 | Uso de derivados de lipasa estimulada por sales biliares humanas para la preparacion de medicamentos. |
Country Status (44)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP930935A2 (en) * | 1992-06-11 | 1994-12-31 | Astra Ab | New dna sequences |
| IS4130A (is) * | 1993-03-01 | 1994-09-02 | Ab Astra | Ný fjölpeptíð |
| SE9300686D0 (sv) | 1993-03-01 | 1993-03-01 | Astra Ab | Novel polypeptides |
| FR2754827B1 (fr) * | 1996-10-17 | 1998-12-24 | Biocem | Lipases pancreatiques et/ou colipases recombinantes et polypeptides dervies produits par les plantes, leurs procedes d'obtention et leurs utilisations |
| JP2000026311A (ja) * | 1998-07-02 | 2000-01-25 | Amano Pharmaceut Co Ltd | 胃排出能亢進剤組成物 |
| US20090226904A1 (en) * | 2005-12-01 | 2009-09-10 | University Of Bergen | Diagnosis and treatment of exocrine pancreatic dysfunction and diabetes |
| SI3205351T1 (sl) * | 2010-04-23 | 2023-09-29 | Alexion Pharmaceuticals, Inc., | Encim za bolezen lizosomskega shranjevanja |
| SG188456A1 (en) | 2010-09-09 | 2013-04-30 | Synageva Biopharma Corp | Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients |
| CA2812852A1 (en) | 2010-10-21 | 2012-04-26 | Swedish Orphan Biovitrum Ab (Publ) | Method to increase the absorption of unsaturated fatty acids by human infants |
| CN103200957A (zh) | 2010-10-21 | 2013-07-10 | 瑞典孤儿比奥维特鲁姆有限公司 | 提高人婴儿之生长速度的方法 |
| UY37680A (es) | 2017-06-19 | 2019-01-31 | Swedish Orphan Biovitrum Ab Publ | Proteína de fusión con polipéptido de extensión de vida media |
| AU2020336468A1 (en) | 2019-08-30 | 2022-03-03 | Societe Des Produits Nestle S.A. | Engineered lipase variants |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0131418A1 (en) * | 1983-07-01 | 1985-01-16 | Celltech Limited | Proteins, pharmaceutical compositons, genes, vectors, host organisms and processes for their production |
-
1990
- 1990-06-01 SE SE9001985A patent/SE9001985D0/xx unknown
-
1991
- 1991-05-17 ZA ZA913778A patent/ZA913778B/xx unknown
- 1991-05-18 TW TW080103838A patent/TW221712B/zh not_active IP Right Cessation
- 1991-05-20 DZ DZ910064A patent/DZ1503A1/fr active
- 1991-05-22 NZ NZ238223A patent/NZ238223A/xx not_active IP Right Cessation
- 1991-05-23 MY MYPI91000877A patent/MY111245A/en unknown
- 1991-05-27 IL IL9827391A patent/IL98273A/xx not_active IP Right Cessation
- 1991-05-29 MA MA22438A patent/MA22166A1/fr unknown
- 1991-05-29 EG EG33391A patent/EG19937A/xx active
- 1991-05-29 YU YU95191A patent/YU49138B/sh unknown
- 1991-05-30 RO RO92-01490A patent/RO114793B1/ro unknown
- 1991-05-30 DE DE69125489T patent/DE69125489T2/de not_active Expired - Lifetime
- 1991-05-30 AT AT91911030T patent/ATE151077T1/de not_active IP Right Cessation
- 1991-05-30 UA UA93003780A patent/UA39165C2/uk unknown
- 1991-05-30 AU AU79645/91A patent/AU651979B2/en not_active Expired
- 1991-05-30 HU HU9203774A patent/HU215258B/hu unknown
- 1991-05-30 IE IE184491A patent/IE911844A1/en not_active IP Right Cessation
- 1991-05-30 JP JP91510382A patent/JPH05507201A/ja active Pending
- 1991-05-30 PL PL91296937A patent/PL166534B1/pl unknown
- 1991-05-30 EP EP91911030A patent/EP0535048B1/en not_active Expired - Lifetime
- 1991-05-30 WO PCT/SE1991/000381 patent/WO1991018923A1/en active IP Right Grant
- 1991-05-30 RU RU92016526/13A patent/RU2140983C1/ru active
- 1991-05-30 SG SG1996006887A patent/SG48078A1/en unknown
- 1991-05-30 CA CA002083396A patent/CA2083396C/en not_active Expired - Lifetime
- 1991-05-30 DK DK91911030.4T patent/DK0535048T3/da active
- 1991-05-30 ES ES91911030T patent/ES2099159T3/es not_active Expired - Lifetime
- 1991-05-31 PT PT97836A patent/PT97836B/pt not_active IP Right Cessation
- 1991-05-31 IS IS3710A patent/IS1751B/is unknown
- 1991-05-31 TN TNTNSN91041A patent/TNSN91041A1/fr unknown
- 1991-05-31 SK SK1644-91A patent/SK281089B6/sk not_active IP Right Cessation
- 1991-05-31 CZ CS19911644A patent/CZ287470B6/cs not_active IP Right Cessation
- 1991-06-01 CN CN91104368A patent/CN1075113C/zh not_active Expired - Lifetime
- 1991-06-01 JO JO19911694A patent/JO1694B1/en active
- 1991-06-01 AP APAP/P/1991/000270A patent/AP207A/en active
- 1991-10-11 PH PH43285A patent/PH30761A/en unknown
-
1992
- 1992-10-01 HR HRP-951/91A patent/HRP920771B1/xx not_active IP Right Cessation
- 1992-11-24 NO NO19924528A patent/NO322962B1/no not_active IP Right Cessation
- 1992-11-26 BG BG97123A patent/BG61165B1/bg unknown
- 1992-11-30 KR KR1019920703049A patent/KR100212411B1/ko not_active IP Right Cessation
- 1992-11-30 FI FI925453A patent/FI114639B/fi active IP Right Grant
-
1993
- 1993-07-30 LV LVP-93-1005A patent/LV10292B/en unknown
- 1993-12-30 LT LTIP1736A patent/LT4020B/lt not_active IP Right Cessation
-
1997
- 1997-05-08 HK HK62497A patent/HK62497A/xx not_active IP Right Cessation
- 1997-05-30 GR GR970401262T patent/GR3023618T3/el unknown
-
2000
- 2000-11-20 CN CN00130975A patent/CN1326782A/zh active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2099159T3 (es) | Uso de derivados de lipasa estimulada por sales biliares humanas para la preparacion de medicamentos. | |
| EP0400958A3 (en) | Live vaccines | |
| Stringham et al. | Targeted single‐cell induction of gene products in Caenorhabditis elegans: a new tool for developmental studies | |
| GB9517779D0 (en) | Biological manipulation | |
| BR0008188A (pt) | Inibidores de fator de diferenciação de crescimento e usos para os mesmos | |
| NO981944D0 (no) | Lipopolyaminer som transfeksjonsmidler samt farmas÷ytisk anvendelse derav | |
| NO820090L (no) | Fremgangsmaate for fremstilling og behandling av renninderivater | |
| BR0210839A (pt) | Sistema de recombinação, método para remover uma sequência de dna do dna cromossÈmico de uma célula ou organismo eucarióticos, organismo, cultura de célula, órgão, tecido, parte ou material de propagação transgênico, e, uso de um organismo ou de uma cultura de célula, órgão, tecido, parte ou material de propagação transgênico | |
| YU128789A (sh) | Postupak za dobijanje područja alkoholne oksidaze ii pichia pastoris-a | |
| RU94046200A (ru) | Последовательности днк, производные последовательностей днк, плазмиды, способ применения последовательностей, способ применения плазмид, трансгенные растения | |
| DE3681738D1 (es) | ||
| ES2139578T3 (es) | Composiciones y procedimiento para modular la actividad del arn mediante la modificacion de la estructura protectora 5' del arn. | |
| BR9811014A (pt) | "região concentrada reguladora de gene especìfica para semente precoce" | |
| ATE15693T1 (de) | Zellkultur-verfahren. | |
| Echeverri et al. | The Axolotl's journey to the modern molecular era | |
| Miljkovic et al. | Cnidarian and bilaterian promoters can direct GFP expression in transfected hydra | |
| ATE355362T1 (de) | Verfahren zur induzierung der osteoblastischen differenzierung der zellen des menschlichen extramedullären fettgewebes | |
| Brock | Growth, developmental, and longevity rhythms in Campanularia flexuosa | |
| DE3851398D1 (de) | DNA-Fragmente, die ein für Milchsäurebakterien spezifisches Regulationsgebiet enthalten, zur Expression von Genen, die normalerweise heterologe Proteine kodieren. | |
| DE69233339D1 (de) | Expressionsteigerung durch Gentargeting in endogene Retrovirus-ähnliche Sequenzen | |
| BR0213413A (pt) | Famìlia da proteìna de ee3 e sequências de dna subordinadas | |
| Velasquez Pulgarin et al. | Light induced expression of gRNA allows for optogenetic gene editing of T lymphocytes in vivo | |
| DK114486A (da) | Piperazinylmethyl-1,2,4-triazolylmethylcarbinoler, fremgangsmaade til fremstilling deraf og deres anvendelse som plantebeskyttelsesmidler | |
| JPS6248376A (ja) | 細胞の培養法 | |
| BRANT et al. | Shuttle vector plasmid propagation in human peripheral blood lymphocytes facilitated by liposome-mediated transfection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 535048 Country of ref document: ES |